argenx

About argenx

argenx is a biotechnology company focused on transforming immunology and delivering innovative medicines for patients with autoimmune diseases. The company is known for its first-in-class neonatal Fc receptor blocker, VYVGART, which has been approved for the treatment of gMG and has the potential to address various severe autoimmune conditions.

Career Opportunities

At argenx, employees are encouraged to grow professionally in a dynamic and collaborative environment that values innovation and teamwork. The company fosters a culture where individuals can make a significant impact on patient lives through their work.

• Opportunities for professional development and growth
• A collaborative and inclusive work culture
• The chance to contribute to groundbreaking advancements in healthcare